Two Sigma Securities, LLC Seagen Inc. Call Options Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $229,662 - $365,544	1,800 New	1,800 $364,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $771,039 - $1.03 Million	5,700 Added 183.87%	8,800 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $337,311 - $555,923	3,100 New	3,100 $549,000
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $171,084 - $229,032	-1,200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $170,940 - $203,784	1,200 New	1,200 $204,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.